(Q34793171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Lizarraga F

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Maldonado V

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Melendez-Zajgla J

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

published in

Journal of Chemotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

348-354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

Estimating the world cancer burden: Globocan 2000.

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

First-line treatment strategies to improve survival in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Control of oncogenesis and cancer therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Toxic proteins released from mitochondria in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Autocatalytic processing of HtrA2/Omi is essential for induction of caspase-dependent cell death through antagonizing XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

The C-terminal tail of presenilin regulates Omi/HtrA2 protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Specific protein interaction of human Pag with Omi/HtrA2 and the activation of the protease activity of Omi/HtrA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Oxaliplatin activity in head and neck cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.3.348

10.1179/JOC.2008.20.3.348

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18606591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference